Insider Selling: American Well Co. (NYSE:AMWL) CFO Sells 5,177 Shares of Stock

American Well Co. (NYSE:AMWL) CFO Robert Shepardson sold 5,177 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.87, for a total transaction of $40,742.99. Following the sale, the chief financial officer now owns 112,992 shares in the company, valued at $889,247.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Robert Shepardson also recently made the following trade(s):

• On Monday, July 1st, Robert Shepardson sold 876 shares of American Well stock. The stock was sold at an average price of $6.00, for a total transaction of $5,256.00.

American Well Trading Up 2.7 %

AMWL opened at $8.00 on Friday. The company’s 50 day moving average is $8.10 and its 200-day moving average is $11.39. American Well Co. has a 1-year low of $5.00 and a 1-year high of $31.60. The company has a market cap of $118.58 million, a P/E ratio of -0.33 and a beta of 1.04.

American Well (NYSE:AMWL) last posted its earnings results on Wednesday, July 31st. The company reported ($3.36) earnings per share for the quarter, topping analysts’ consensus estimates of ($3.94) by $0.58. American Well had a negative net margin of 120.44% and a negative return on equity of 50.36%. The firm had revenue of $62.79 million for the quarter, compared to analyst estimates of $60.78 million. During the same period in the previous year, the firm posted ($4.60) EPS. On average, equities analysts forecast that American Well Co. will post -13.91 EPS for the current year.

Wall Street Analyst Weigh In

AMWL has been the topic of a number of research analyst reports. UBS Group reduced their price target on shares of American Well from $30.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday, May 23rd. Wells Fargo & Company reduced their price target on shares of American Well from $40.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of American Well in a research note on Thursday, August 1st.

Institutional Investors Weigh In On American Well

Institutional investors have recently added to or reduced their stakes in the business. Point72 DIFC Ltd grew its holdings in American Well by 1,418.5% during the 2nd quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock worth $34,000 after acquiring an additional 96,644 shares during the last quarter. Oak Thistle LLC bought a new stake in American Well during the 1st quarter worth approximately $46,000. Cubist Systematic Strategies LLC grew its holdings in American Well by 7,673.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock worth $60,000 after acquiring an additional 181,715 shares during the last quarter. Cowen AND Company LLC bought a new stake in American Well during the 2nd quarter worth approximately $81,000. Finally, RPO LLC acquired a new position in shares of American Well in the 4th quarter worth approximately $85,000. 56.05% of the stock is owned by institutional investors.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.